van Wijngaarden I - Search Results

1

Hybrid cholecystokinin-A antagonists based on molecular modeling of lorglumide and L-364,718.

van der Bent A, Blommaert AG, Melman CT, IJzerman AP, van Wijngaarden I, Soudijn W. van der Bent A, et al. Among authors: van wijngaarden i. J Med Chem. 1992 Mar 20;35(6):1042-9. doi: 10.1021/jm00084a009. J Med Chem. 1992. PMID: 1552499

2

Medicinal chemistry of adenosine A1 receptor ligands.

Soudijn W, van Wijngaarden I, IJzerman AP. Soudijn W, et al. Among authors: van wijngaarden i. Curr Top Med Chem. 2003;3(4):355-67. doi: 10.2174/1568026033392165. Curr Top Med Chem. 2003. PMID: 12570755 Review.

3

A series of N4-imidoethyl derivatives of 1-(2,3-dihydro-1,4-benzodioxin-5-yl)piperazine as 5-HT1A receptor ligands: synthesis and structure-affinity relationships.

van Steen BJ, van Wijngaarden I, Tulp MT, Soudijn W. van Steen BJ, et al. Among authors: van wijngaarden i. J Med Chem. 1995 Oct 13;38(21):4303-8. doi: 10.1021/jm00021a020. J Med Chem. 1995. PMID: 7473558

4

N4-unsubstituted N1-arylpiperazines as high-affinity 5-HT1A receptor ligands.

Kuipers W, van Wijngaarden I, Kruse CG, ter Horst-van Amstel M, Tulp MT, IJzerman AP. Kuipers W, et al. Among authors: van wijngaarden i. J Med Chem. 1995 May 26;38(11):1942-54. doi: 10.1021/jm00011a014. J Med Chem. 1995. PMID: 7783126

5

Structure-affinity relationship studies on 5-HT1A receptor ligands. 2. Heterobicyclic phenylpiperazines with N4-aralkyl substituents.

van Steen BJ, van Wijngaarden I, Tulp MT, Soudijn W. van Steen BJ, et al. Among authors: van wijngaarden i. J Med Chem. 1994 Aug 19;37(17):2761-73. doi: 10.1021/jm00043a015. J Med Chem. 1994. PMID: 8064803

6

Structure-affinity relationship studies on 5-HT1A receptor ligands. 1. Heterobicyclic phenylpiperazines with N4-alkyl substituents.

van Steen BJ, van Wijngaarden I, Tulp MT, Soudijn W. van Steen BJ, et al. Among authors: van wijngaarden i. J Med Chem. 1993 Sep 17;36(19):2751-60. doi: 10.1021/jm00071a006. J Med Chem. 1993. PMID: 8410989

7

5-HT1A-versus D2-receptor selectivity of flesinoxan and analogous N4-substituted N1-arylpiperazines.

Kuipers W, Kruse CG, van Wijngaarden I, Standaar PJ, Tulp MT, Veldman N, Spek AL, IJzerman AP. Kuipers W, et al. Among authors: van wijngaarden i. J Med Chem. 1997 Jan 31;40(3):300-12. doi: 10.1021/jm960496o. J Med Chem. 1997. PMID: 9022796

8

The GABA transporter and its inhibitors.

Soudijn W, van Wijngaarden I. Soudijn W, et al. Among authors: van wijngaarden i. Curr Med Chem. 2000 Oct;7(10):1063-79. doi: 10.2174/0929867003374363. Curr Med Chem. 2000. PMID: 10911018 Review.

9

1H-imidazo[4,5-c]quinolin-4-amines: novel non-xanthine adenosine antagonists.

van Galen PJ, Nissen P, van Wijngaarden I, IJzerman AP, Soudijn W. van Galen PJ, et al. Among authors: van wijngaarden i. J Med Chem. 1991 Mar;34(3):1202-6. doi: 10.1021/jm00107a046. J Med Chem. 1991. PMID: 2002461

10

Structure-activity relationships of inverse agonists for G-protein-coupled receptors.

Soudijn W, van Wijngaarden I, Ijzerman AP. Soudijn W, et al. Among authors: van wijngaarden i. Med Res Rev. 2005 Jul;25(4):398-426. doi: 10.1002/med.20031. Med Res Rev. 2005. PMID: 15816047 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

44 results

Search Page